VOYA Investment Management’s Lifecore Biomedical LFCR Stock Holding History

VOYA Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,188	Closed	-$42.2K	–	2967
2023 Q1	$42.2K	Hold	11,188	–	–	﹤0.01%	2827
2022 Q4	$72.5K	Hold	11,188	–	–	﹤0.01%	2810
2022 Q3	$99.5K	Hold	11,188	–	–	﹤0.01%	2781
2022 Q2	$112K	Hold	11,188	–	–	﹤0.01%	2585
2022 Q1	$130K	Hold	11,188	–	–	﹤0.01%	2470
2021 Q4	$124K	Sell	11,188 -709	-6%	-$6.88K	﹤0.01%	2632
2021 Q3	$110K	Hold	11,897	–	–	﹤0.01%	2716
2021 Q2	$134K	Sell	11,897 -971	-8%	-$11.2K	﹤0.01%	2706
2021 Q1	$136K	Buy	12,868 +1,155	+10%	+$13K	﹤0.01%	2624
2020 Q4	$127K	Buy	+11,713	New	+$121K	﹤0.01%	2518
2020 Q2	–	Sell	-12,765	Closed	-$111K	–	2563
2020 Q1	$111K	Hold	12,765	–	–	﹤0.01%	2315
2019 Q4	$144K	Buy	+12,765	New	+$136K	﹤0.01%	2463
2019 Q3	–	Sell	-10,384	Closed	-$97K	–	2565
2019 Q2	$97K	Sell	10,384 -1,226	-11%	-$12.4K	﹤0.01%	2476
2019 Q1	$143K	Sell	11,610 -1,327	-10%	-$16.2K	﹤0.01%	2356
2018 Q4	$153K	Hold	12,937	–	–	﹤0.01%	2296
2018 Q3	$186K	Hold	12,937	–	–	﹤0.01%	2357
2018 Q2	$193K	Sell	12,937 -1,583	-11%	-$22K	﹤0.01%	2370
2018 Q1	$189K	Sell	14,520 -1,744	-11%	-$22.9K	﹤0.01%	2343
2017 Q4	$205K	Sell	16,264 -1,162	-7%	-$14.7K	﹤0.01%	2339
2017 Q3	$226K	Sell	17,426 -4,253	-20%	-$56.1K	﹤0.01%	2325
2017 Q2	$322K	Buy	21,679 +1,603	+8%	+$22.3K	﹤0.01%	2113
2017 Q1	$241K	Hold	20,076	–	–	﹤0.01%	2180
2016 Q4	$277K	Hold	20,076	–	–	﹤0.01%	2108
2016 Q3	$269	Hold	20,076	–	–	﹤0.01%	2112
2016 Q2	$216K	Hold	20,076	–	–	﹤0.01%	2212
2016 Q1	$211K	Hold	20,076	–	–	﹤0.01%	2185
2015 Q4	$237K	Hold	20,076	–	–	﹤0.01%	2192
2015 Q3	$234K	Hold	20,076	–	–	﹤0.01%	2187
2015 Q2	$290K	Hold	20,076	–	–	﹤0.01%	2286
2015 Q1	$280K	Sell	20,076 -8,790	-30%	-$121K	﹤0.01%	2271
2014 Q4	$399K	Hold	28,866	–	–	﹤0.01%	2089
2014 Q3	$354K	Hold	28,866	–	–	﹤0.01%	2141
2014 Q2	$361K	Sell	28,866 -2,658	-8%	-$31.3K	﹤0.01%	2223
2014 Q1	$352K	Hold	31,524	–	–	﹤0.01%	2232
2013 Q4	$382K	Hold	31,524	–	–	﹤0.01%	2152
2013 Q3	$385K	Hold	31,524	–	–	﹤0.01%	2103
2013 Q2	$416K	Buy	+31,524	New	+$436K	﹤0.01%	1979

Other funds holding LFCR

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

VOYA Investment Management's LFCR Position: Q2 2023 in Review

VOYA Investment Management sold out of Lifecore Biomedical (LFCR) in Q2 2023, closing a stake of 11,188 shares — an estimated $42.2K sold.

VOYA Investment Management first reported a position in LFCR in Q2 2013 and held it in 37 quarters. The position peaked at $416K in Q2 2013. 75 funds tracked by Wall St. Rank hold LFCR as of Q2 2023.

VOYA Investment Management reported no remaining Lifecore Biomedical position as of Q2 2023 after selling out during the quarter.
VOYA Investment Management sold 11,188 Lifecore Biomedical shares in Q2 2023, an estimated $42.2K.
VOYA Investment Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 37 quarters.
VOYA Investment Management's Lifecore Biomedical position peaked at $416K in Q2 2013.
75 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.